|Bid||90.68 x 800|
|Ask||90.90 x 2900|
|Day's Range||88.95 - 91.03|
|52 Week Range||70.89 - 95.72|
|Beta (5Y Monthly)||0.32|
|PE Ratio (TTM)||13.90|
|Forward Dividend & Yield||2.76 (3.03%)|
|Ex-Dividend Date||Sept 14, 2022|
|1y Target Est||N/A|
ResMed (RMD) posts better-than-expected Q4 results with continued strength in sleep and respiratory care devices sales performance.
J&J (JNJ) will stop selling its talcum-based baby powder globally from next year. Though reports claim that the use of the talc causes cancer, JNJ maintains its stance that this product is safe.
Revenue growth at STERIS' (STE) Applied Sterilization Technologies is driven by increased demand from medical device and biopharma customers.